Tissue penetration of antimicrobials: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
!CNS |
!CNS |
||
!Urine |
!Urine |
||
!Prostate |
|||
!Necrotic |
!Necrotic |
||
|- |
|- |
||
! colspan=" |
! colspan="7" |Antibiotics: β-Lactams |
||
|- |
|- |
||
| rowspan="2" |Penicillins |
| rowspan="2" |Penicillins |
||
|β-lactamase inhibitors |
|β-lactamase inhibitors |
||
| |
| |
||
| |
|– |
||
⚫ | |||
| |
| |
||
| |
| |
||
Line 18: | Line 20: | ||
|[[ampicillin]] |
|[[ampicillin]] |
||
| |
| |
||
| |
| + |
||
| |
| |
||
| |
| |
||
|– |
|||
|- |
|- |
||
| rowspan="4" |Cephalosporins |
| rowspan="4" |Cephalosporins |
||
|first-generation cephalosporins |
|first-generation cephalosporins |
||
| |
| |
||
| |
|– |
||
| |
|||
| |
| |
||
| |
|– |
||
|- |
|- |
||
|second-generation cephalosporins |
|second-generation cephalosporins |
||
| |
| |
||
| |
|– |
||
| |
|||
| |
| |
||
| |
| |
||
Line 39: | Line 44: | ||
| |
| |
||
| |
| |
||
| |
| |
||
| + |
|||
|- |
|- |
||
|[[ceftazidime]] |
|[[ceftazidime]] |
||
| |
| |
||
| |
| + |
||
| |
| |
||
| |
| |
||
| + |
|||
|- |
|- |
||
| rowspan="2" |Cephamycins |
| rowspan="2" |Cephamycins |
||
|[[cephamycins]] |
|[[cephamycins]] |
||
| |
| |
||
| |
|– |
||
| |
|||
| |
| |
||
| |
| |
||
Line 58: | Line 66: | ||
| |
| |
||
| |
| |
||
| |
| |
||
|– |
|||
|- |
|- |
||
|Carbapenems |
|Carbapenems |
||
Line 65: | Line 74: | ||
| |
| |
||
| |
| |
||
| |
| |
||
| + |
|||
|- |
|||
! colspan="7" |Antibiotics: Non-β-Lactams |
|||
|- |
|- |
||
|Aminoglycosides |
|Aminoglycosides |
||
Line 72: | Line 84: | ||
| |
| |
||
| |
| |
||
| |
| |
||
|– |
|||
|- |
|||
⚫ | |||
|[[chloramphenicol]] |
|||
| |
|||
| |
|||
| |
|||
| |
|||
| + |
|||
|- |
|- |
||
|Fluoroquinolones |
|Fluoroquinolones |
||
| |
| |
||
| |
| |
||
| |
|–? |
||
| |
| |
||
| |
| + |
||
| + |
|||
|- |
|- |
||
|Lincosamides |
|Lincosamides |
||
|[[clindamycin]] |
|[[clindamycin]] |
||
| |
| |
||
| |
|– |
||
| |
| |
||
| |
| |
||
| + |
|||
|- |
|- |
||
|Macrolides |
|Macrolides |
||
|[[macrolides]] |
|||
| |
| |
||
|– |
|||
| |
| |
||
| |
| + |
||
⚫ | |||
| |
| |
||
|- |
|||
|Nitrofurans |
|||
|[[nitrofurantoin]] |
|||
|– |
|||
|– |
|||
| + |
|||
|– |
|||
|– |
|||
|- |
|- |
||
|Nitroimidazoles |
|Nitroimidazoles |
||
Line 100: | Line 132: | ||
| |
| |
||
| |
| |
||
| |
| |
||
| + |
|||
|- |
|- |
||
|Rifamycins |
|||
⚫ | |||
|[[ |
|[[rifampin]] |
||
| |
| |
||
|NO |
|||
| |
| |
||
| |
|||
| + |
|||
| |
| |
||
|- |
|- |
||
|Sulfonamides |
|||
⚫ | |||
|[[sulfamethoxazole]] |
|||
| |
| |
||
| |
| |
||
| |
| |
||
| |
|– |
||
| |
|||
|- |
|- |
||
⚫ | |||
⚫ | |||
|[[ |
|[[tetracyclines]] |
||
| |
| |
||
|– |
|||
| |
| |
||
| + |
|||
| |
| |
||
|YES |
|||
|- |
|- |
||
⚫ | |||
⚫ | |||
| |
|||
| |
|||
| |
|||
| |
|||
| + |
|||
|- |
|||
⚫ | |||
|- |
|- |
||
|Azoles |
|Azoles |
||
Line 129: | Line 173: | ||
| |
| |
||
| |
| |
||
| |
| |
||
| + |
|||
|} |
|} |
||
[[Category:Antimicrobials]] |
[[Category:Antimicrobials]] |
Revision as of 16:16, 24 August 2020
Class | Antimicrobial | Blood | CNS | Urine | Prostate | Necrotic |
---|---|---|---|---|---|---|
Antibiotics: β-Lactams | ||||||
Penicillins | β-lactamase inhibitors | – | ||||
ampicillin | + | – | ||||
Cephalosporins | first-generation cephalosporins | – | – | |||
second-generation cephalosporins | – | |||||
cefepime | + | |||||
ceftazidime | + | + | ||||
Cephamycins | cephamycins | – | ||||
cefoxitin | – | |||||
Carbapenems | imipenem | + | ||||
Antibiotics: Non-β-Lactams | ||||||
Aminoglycosides | – | |||||
Chloramphenicol | chloramphenicol | + | ||||
Fluoroquinolones | –? | + | + | |||
Lincosamides | clindamycin | – | + | |||
Macrolides | macrolides | – | + | |||
Nitrofurans | nitrofurantoin | – | – | + | – | – |
Nitroimidazoles | metronidazole | + | ||||
Rifamycins | rifampin | + | ||||
Sulfonamides | sulfamethoxazole | – | ||||
Tetracyclines | tetracyclines | – | + | |||
doxycycline | + | |||||
Antifungals | ||||||
Azoles | fluconazole | + |
References
- ^ Cornelia B. Landersdorfer, Jürgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz Sörgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.
- ^ L. Brockhaus, D. Goldblum, L. Eggenschwiler, S. Zimmerli, C. Marzolini. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clinical Microbiology and Infection. 2019;25(11):1364-1369. doi:10.1016/j.cmi.2019.01.017.